Ceradyne, Inc. (CRDN) Misses Q4 EPS by 5c; Issues FY12 Outlook
Tweet
Share
E-mailGet Alerts CRDN Hot Sheet
Price: $35.00 --0%
Financial Fact:
Other Income (Expense), Total: -1.98M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Other Income (Expense), Total: -1.98M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Ceradyne, Inc. (NASDAQ: CRDN) reported Q4 EPS of $0.56, $0.05 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $128.5 million versus the consensus estimate of $131.94 million.
Ceradyne, Inc. sees FY2012 EPS of $2.30-$2.65, versus the consensus of $2.71. Ceradyne, Inc. sees FY2012 revenue of $590-$625 million, versus the consensus of $581.6 million.
For earnings history and earnings-related data on Ceradyne, Inc. (CRDN) click here.
Ceradyne, Inc. sees FY2012 EPS of $2.30-$2.65, versus the consensus of $2.71. Ceradyne, Inc. sees FY2012 revenue of $590-$625 million, versus the consensus of $581.6 million.
For earnings history and earnings-related data on Ceradyne, Inc. (CRDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Cuprina to buy seven-clinic Singapore healthcare group for S$4M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
